Anúncio
Anúncio

SRTS

SRTS logo

Sensus Healthcare, Inc

3.70
USD
Patrocinado
-0.01
-0.29%
30 de dez., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

3.83

+0.13
+3.54%

Relatórios de Lucros SRTS

Rácio de surpresa positiva

SRTS separação 24 de 37 últimas estimativas.

65%

Próximo Relatório

Data do Próximo Relatório
03 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.51M
/
-$0.07
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+23.65%
/
+16.67%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-34.86%
/
-177.78%

Sensus Healthcare, Inc earnings per share and revenue

On 06 de nov. de 2025, SRTS reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 38.08% surprise. Revenue reached 6.88 milhão, compared to an expected 6.44 milhão, with a 6.91% difference. The market reacted with a +19.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.07 USD, with revenue projected to reach 8.51 milhão USD, implying an aumentar of 16.67% EPS, and aumentar of 23.65% in Revenue from the last quarter.
FAQ
For Q3 2025, Sensus Healthcare, Inc reported EPS of -$0.06, beating estimates by 38.08%, and revenue of $6.88M, 6.91% above expectations.
The stock price moved up 19.32%, changed from $3.52 before the earnings release to $4.20 the day after.
The next earning report is scheduled for 03 de fev. de 2026.
Based on 5 analistas, Sensus Healthcare, Inc is expected to report EPS of -$0.07 and revenue of $8.51M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio